The Money Map folks have decided that it’s time to go “all in” on cannabis, and for them that means starting a new investment research business that they call the National Institute for Cannabis Investors, and selling memberships in that group by teasing their favorite “special reports” on some appealing marijuana stocks that they’ll give you once your credit card payment goes through.
It’s not a terribly expensive membership, as these things go, so we should consider this to be their “entry level” deal — their real goal, I imagine, is to build up their list of people who are interested in pot stocks so they can sell a “bigger, better” super-premium service next time around… but that’s just how the newsletter marketing business works, “entry level” $39 or $79 subscriptions that get funneled into $2,000 or $4,999 subscriptions where the real profits are. Nothing different here, except that instead of selling Dr. Kent Moors oil stocks or Ernie Tremblays biotech ideas, they’re selling someone’s cannabis picks.
And whose are they? Well, Michael Robinson and Ernie Tremblay are both on the “advisory board” of this group, and I would assume they’ll headline the stock selection since they’re both newsletter pundits with Money Map already (and have both written about marijuana plenty in the past), but the name they’re using most aggressively to sell the service is John Boehner, the former Speaker of the House of Representatives who famously changed tack on marijuana after leaving office and now favors legalization (and, not coincidentally, works for a marijuana investment fund called Acreage Holdings) — along with Danny Brody, who is an “industry representative” on the board (he runs Investor Relations for The Green Organic Dutchman and had a similar role at Emblem, both fairly large Canadian cannabis companies).
The “Cannabis Summit” is mostly John Boehner, Mike Ward and Danny Brody talking up the huge potential of cannabis in general, but they do also flog four “special reports” on particular companies that they think will be good investments… so that’s what I was interested in, the teases and hints about those four companies. I’ll skip over the big picture stuff about removing Marijuana from the DEA’s Schedule 1, changing tax laws, opening up banking to pot companies, pushing more legalization, etc, but if you want to see all that chatter you can check out the transcript of the “Summit” here.
For us, we’re interested in stocks — so let’s see if we can name the ones they’re teasing, shall we?
They open this part of the “summit” by saying that…
“… we’re also going to examine the three cannabis investment opportunities our viewers should consider immediately….
“The next generation of billion-dollar cannabis companies are ripe for the picking.”
And then the clues for our first stock:
“SPEAKER JOHN BOEHNER: We believe we’ve got somebody who is ready to capture a big piece of the $1.1 trillion pharmaceutical industry.
“Cannabis is just starting to break into this market.
“The FDA approving GW Pharmaceutical’s epilepsy treatment was only a sign of things to come.
“Cannabis drugs for epilepsy could be a $5 billion opportunity….
“We believe the company we’re recommending has an even better treatment.
“And it’s not just for epilepsy….
“The guys we’re looking at were one of the first to prove CBD could be used to stop epileptic seizures.
“Now, if you’re taking cannabis purely for medical reasons, you are going to want something with as little THC as possible – but the purest dose of CBD you can get.”
THC is the psychoactive stuff, the fun part of marijuana — CBD is, many folks believe, the potential health-altering stuff, and the stuff that people seem to be a lot more comfortable giving to their children. And you’ve probably seen hemp or CBD supplements, for sale in health food stores or online, so you know it’s not nearly as controlled as the stuff that gives you a high (even if a lot of that stuff in health food stores is in a bit of a grey area and might technically be illegal, more on that in a moment).
More clues:
“The firm we’re targeting has created:
- 12 liquid versions of their CBD treatment at different strengths.
- Four pill-based products.
- Four topical creams and lotions.
- They even have two different CBD treatments for dogs.
“And here’s an enormous competitive advantage.
“You need a prescription for GW’s drug.
Are you getting our free Daily Update
"reveal" emails? If not,
just click here...“All of our firm’s products are available over the counter.”
And also a lot cheaper than prescription drugs, we’re told, at $99 a month. We get a bit more talk about how CBD oil and/or marijuana are also important to helping fight the opioid epidemic, both because they can work on pain and because they’re helpful in addiction treatment, and that they also have a huge potential market in non-prescription sleep aids that don’t have the side effects of Ambien and other sleeping pills.
More hints:
“… the firm we’ve identified is set to capture the lion’s share of this market.
“I think we should stress again that they can sell their products over-the-counter, without a prescription.
“They’re already on the shelves at 2,700 retail stores across the country.
“And year-over-year, their revenue has jumped 172%.
“But there is a great deal of room for growth still.
“We’ve learned they’ve been talking to Target.”
Other clues? They went public recently, with an IPO “a couple months ago” … and that’s about it. They call the “special report” on this one “Prescription-Free CBD:
The Firm Set to Disrupt the $1.1 Trillion Pharmaceutical Industry.” Ready?
The Thinkolator was a little slow to start up this morning, with a bit of frost on the dust ruffle, but a few sharp pulls got us going… and a few shovels full of those clues got our answer, hot and fresh: This is Charlotte’s Web Holdings (CWEB.CX on the CSE in Canada, CWBHF OTC in the US), a Colorado maker of CBD oil and similar extract products that was founded by the Stanley brothers a few years ago.
The Charlotte name is an important part of their branding, but she’s also a real person — they have lots of background info on their website, which is very branding-focused, including the back story of how the Stanley Brothers developed this low-THC strain of cannabis that became widely used in alternative remedies. Charlotte Figi was a girl who was treated for her Dravet syndrome using this strain, apparently, and saw her seizures improve dramatically, and her story was a high-profile part of the legalization of medical marijuana starting about five years ago (she was in a CNN documentary). Charlotte’s Web is both the name of the company now, and the name of the cannabis strain that was developed to be high in cannabidiol (CBD) and low in tetrahydrocannabinol (THC). There may well be other strains that are similar now, I have no idea, but there’s certainly a lot of marketing now behind this Charlotte’s Web product.
And it’s pretty impressive, particularly for those of us who think that marketing and branding will be the most important thing to watch for the next several years of “normalization” of marijuana and cannabis in the US (and Canada, though Canada is obviously a few jumps ahead of us with full recreational legalization). They do say they have their hemp extract oil product in 2,700 stores now, with lots more distribution planned, and their products were briefly in Target stores before Target was contacted by the DEA and stopped selling them last year… which is probably the largest risk here, that their hemp extract oil is in a legal and regulatory grey area — they’d like to market it as a dietary supplement, which means they can sell it almost anywhere as long as they don’t make specific medical claims, but there seems to be some pushback that this should be part of the marijuana legalization/distribution industry, which would add a lot more friction to the sales process.
I don’t know how it will turn out, but according to their Q2 filing they do at least have an impressive ramp-up of revenues so far, with sales almost doubling year over year going into the IPO, and they have been profitable for over a year. Earnings for the first six months of 2018 came in at 73 cents/share, diluted — but that was on 9.4 million shares, and according to this article about the IPO the new total, including both the IPO shares (which were sold at C$7 each) and the promotional super-voting shares, should be about 92.8 million shares.
So with that, the current market cap at C$15.70/share would be about C$1.5 billion — with roughly $100 million in cash. They’re on pace for something like US$15 million of net income this year, so that means we’re looking at a company that’s expected to roughly double revenue and income next year but is trading at at PE of just a bit under 100. That’s pretty expensive, but you can justify paying that kind of multiple if they’re likely to be able to keep doubling revenue each year… and particularly if the business is at all scalable (meaning that they get economies of scale, so profit margins to up as revenues climb).
The company looks pretty appealing if they can keep building market share in their CBD oil business and build a bigger presence for the brand. There are lots and lots of companies out there who sell CBD oil supplements that look very similar to me, both online and in stores, and I’m not really in a position where I can make a call on whether they will be able to exert leadership in that segment… but having $100 million in the bank to spend on marketing and distribution is a good step, and the marketing looks pretty compelling to me, so perhaps it will work.
I haven’t invested myself, but the growth and the profitability to this point are impressive. They’re not at all secret or hidden as a stock, they’ve even been on CNBC, but they are also not really a “marijuana explosion” stock because there won’t be any direct impact from marijuana legalization — they already sell almost exclusively in the US, and are trying to avoid being regulated like THC-focused marijuana and marijuana extracts, so regulatory changes for the industry as a whole could very likely help them, particularly if it clarifies their legal and non-prescription status for wide distribution as a dietary supplement, but they aren’t really directly impacted by Canadian or US legalization of recreational or medicinal marijuana… but so far they are impacted enough by the uncertainty that they had to list on the Canadian Stock Exchange instead of Vancouver or the Nasdaq, just like marijuana stocks that have illegal (on the federal level) US businesses, so clearly there’s still some grey area, which means risk.
Next? Clues for another stock that they call “The Innovator” …
“… time-and-time again what makes money in tech is a basic proposition: ‘You’ve got a big problem – I’ve got a simple solution for it’….
“a regular old, prescription pill bottle.
“Some folks making these bottles refused to work with cannabis companies.
“But you walk into a dispensary and every product you buy is required to come in child-resistant packaging.
“This young man, just out of college, says, ‘I can do that.’
“Some years back, he invents a child-resistant top for a bottle.
“He goes around to all the companies in California and Colorado that are selling cannabis and tells them, ‘Hey, I hear you need this.’
“And he can’t make these bottles fast enough. Everybody is buying them.”
You can probably already guess where this is going if you’ve followed the pot stocks over the past few years, but let’s check a couple other clues:
“They have a wide assortment of products.
“Pre-roll containers. Child-proof, pop-top bottles. You name it….
“They have sold over a billion units….
“In 2014, they sold $1.71 million worth of product.
“This year, they’re at $51 million….
“They count 5,000 cannabis companies as customers.
“And seizing on that opportunity, they bought a digital creative agency that helps their clients with branding.”
Well, they’re not quite at $51 million yet… but they’ve guided to $51 million for their fiscal year ending August 31, so presumably they’ll hit or beat that number. This is, as you might have guessed, KushCo (KSHB), which used to be called Kush Bottles and has been a “picks and shovels” stock tip in marijuana for years. I’ve been too skeptical on this one in the past, mostly because I didn’t think they’d be able to be the only real player in this space over a long period of time, given the huge variety of childproof packaging suppliers that exist and could quickly hit the marijuana market, but perhaps they’re enough of a “first mover” that they can get a strong and loyal customer base and hold off whatever competition arrives. Dunno. There are estimates (by only two analysts) that they’ll be growing revenue at an 80-90% pace over the next two years, which would certainly give them the opportunity to be profitable if that’s their focus — they’ve been doing acquisitions and growing the business instead of looking for earnings thus far, it appears, using stock and a little debt to fuel that growth.
So… KushCo is not necessarily cheap for an unprofitable packaging company, trading at a price/sales ratio of about 7, but they’re cheap for a marijuana company, and probably pretty rationally valued if they can keep up their rapid revenue growth rate and leverage their “first mover” status to keep a strong market share in packaging and branding for cannabis products. I don’t know what other players exist in this space, or how competitive it might become, so that’s where I’d put in my research time if I were considering this stock.
And more?
“SPEAKER JOHN BOEHNER: At Acreage, we’re betting brands are the future of cannabis.
“So what makes a great brand?
“Molson Coors Brewing is a $14 billion company.
“Not because they just sell beer.
“No, they sell brands of beer.
“Brands people like.
“Miller, Coors, and Molson.”
OK, preaching to the choir here — yes, I think brands are likely to be the winners in the marijuana space… but sadly, I don’t know which brands, so I’ve resisted paying crazy valuations for companies that might end up being worthless.
So what’s this brand that they like?
“DANNY BRODY: We believe we’ve identified the next big brand in cannabis.
“They have a lot going for them.
“First, obviously you need a good product.
“They have developed a line of high-quality cannabis oils….
“They’ve recruited top executives from Philip Morris, Coca-Cola, Kraft Foods, and Eli Lilly.
“All major brand builders from the tobacco, beverage, packaged goods, and pharmaceutical industries.
“And these guys developed a workaround to the advertising problem.
“They launched a separate line of nutritional supplements.
“No cannabis in them whatsoever.
“They can advertise and sell them anywhere.”
OK… so they use the same brand to sell both “legal anywhere” nutritional supplements (CBD ones, maybe?), and intoxicating marijuana products. What else?
“Over the last two years, their sales have multiplied 19X.
“To this point, only a couple of cannabis companies have established any brand traction.”
As one example of the power of brands, they note that one of the other appealing brands that was developed, Tokyo Smoke, which was built by Hiku, was acquired by Canopy Growth (CGC, WEED.TO), which is focusing a lot on brands as they try to build on their leadership in Canada… and I should note, as a reminder that “price matters,” that Hiku was teased back in May by a different newsletter and acquired by Canopy Growth just a month or two later at pretty much the same price it was at when Zach Scheidt was teasing it in May. You could have either come out of it with a 50% gain or a 10% loss or anywhere in between, just based on what price you chose to pay over a period of about six weeks.
So which company are they talking about here? Thinkotor sez their pick for “Cannabis’ First Household Name” must be: Emerald Health Therapeutics (EMH.V, EMHTF), which is a Canadian marijuana grower and extract/oil producer that, yes, also has a “nutraceutical” line of products that they’re trying to use to establish a brand presence (particularly the “Endo” line — EndoCalm, EndoBliss, EndoSleep, etc.).
And their revenues have climbed 19X in two years, though that’s largely a meaningless number because the revenue was so close to zero two years ago — they report C$2.1 million in revenue for the past four quarters, which is also almost a meaningless number for a company with a market cap of C$500 million, so it’s clearly all about the future with these guys… as with so many Canadian pot stocks… and I just don’t have a real sense of what the future is going to be when it comes to consumption and consumer preferences.
We’ve seen Emerald before recently, too, they were part of our look at the tease for Village Farms International (VFF.TO, VFFIF) because the two companies have a 50/50 joint venture for the large planned Pure Sunfarms greenhouse complex for low-cost cannabis production. That’s one of half a dozen subsidiaries, including other growers and the Emerald Health Naturals and Northern Vine Labs businesses, you can get a pretty decent picture of their strategy and current business from their latest investor presentation here.
So… the business is barely moving the needle, but they do have an interesting strategy of brand building, some substantial production that should be coming online right now and could boost the revenue up to something measurable over the next couple quarters, and they have $72 million in cash that they will presumably need as they try to continue to invest in their brands and their grow facilities (they’re on the hook for much of that Village Farms project, for example), so… is it worth $500 million today? More? Less? We’d both be guessing at this point, so, since it’s your money, you should probably go with your guess.
And with that, dear friends, I’ll leave you to cogitate on those three “cannabis summit” stocks… I’d guess that Emerald is going to be driven by Canadian production, KushCo by their ability to keep market share in packaging, and Charlotte’s Web by their marketing prowess and the adoption (or lack thereof) of CBD oil as a mass market nutritional supplement. If you’ve got an opinion on any of them, or a forecast you’d like to share (or, for that matter, your preferred three cannabis stocks that you think will outplay that trio), please let us know with a comment below.
FYI, for those trying to get a basic grip of the “non-THC” and non-smoking parts of the cannabis market these days there was interesting article yesterday on CBD here — CBD: A marijuana ‘miracle’ that comes at a very high price … a lot of the same issues as with other unregulated or non-standardized dietary supplements and nutraceuticals.
And another slightly older one here that’s more in-depth from The Guardian: What is CBD? The ‘miracle’ cannabis compound that doesn’t get you high
As always, thank you for deciphering through the cryptic recommendations. My wife is a huge marijuana advocate. So I recently tried CBD products for joint pain. I can’t say it’s a miracle cure. I’m still trying the products and considering these investments. Btw, Oregon had a dispensary nearly every mile and prices may have reflected an over supply.
I bought some EMHTF today…CBD will be the big seller…as it has many uses. Thanks! It’s a long term play!
Travis, you are the best! I watched that hype, pre-recorded session and am so glad to have your analysis and the Thinkolator’s results! Here are my actual experiences with those three companies (plus one other related stock):
Charlotte’s Web Holdings — never bought it because I just thought the stock price was at a bit too high to be a huge winner (not good reasoning).
KushCo — bought at $5.7327, now $5.20 (oops!).
Emerald Health — bought at $1.1944, now $2.52 (pretty good).
and Village Farms — bought at $5.99, now $4.10 (another oops!).
I was intrigued by their $39 offer for one year, mainly because of the lengthy, monthly list of pot stocks with ratings for each and the real-time sell recommendations. Obviously, the latter aspect of buying a stock is always challenging (at least for me) — the “Roach Motel” syndrome of “it’s easy to get in, but when and how do you get out!” As yet, I have not coughed up that paltry fee because I really do not want to get involved at all unless there’s truly something of value there for me. I’ll give them a call. They have my email address; so, it’s not the last time I’ll hear from them!
Caveat Emptor!
Emerald Health will become one of the few
Extremely Profitable Cannabis Companies in
North America within the next 3-5 years with
their experienced Management Team.
A Real True Winner!
Love this stock.
I hope you stuck with Village Farms. It is June 11, 2019 and they are supposedly at just under $13/share under the VFFIF ticker and just over $17/share under the VFF ticker. I don’t know which one you used, but that is a decent increase over an intial $5.99/share.
There’s a stock I’d like to buy if I could: Acreage Holdings. Their Board of Directors includes the former Prime Minister of Canada, Brian Mulroney; the former Governor of Massachusetts, William Weld; and the former Speaker of the House, John Boehner. If that doesn’t make money… But it’s an IPO in November on a Canadian stock. How could I, or you, buy an IPO? and an IPO up there?
I believe Acreage Holding is a private company. Any word if it will go public? I agree that with that kind of high profile individuals on board, it must have some good going on.
November 11, 2018
@ Steven Raimondi
I’m going to need you to state your source. I’ve been trying to find this date for a very long time, and the most I have found is “November” from newcannabisventures.com and “Early November” from greenmarketreport.com
There is nothing on Acreage’s website about an exact date either.
Nov 11, 2018 is a Sunday, markets are closed. Nov 12th is a holiday in the US, so US markets are closed that day as well. How can they have an IPO on days that the markets are closed?
Thanks @ Dice. I guess we will have to keep our eyes and ears open, hopefully Acreage Holdings will send an email alert to those of us signed up on their website.
It will be a reverse takeover with an old Canadian shell company that’s been delisted for years — unless they do a private placement offer at the same time, there’s no way to buy in before they list unless you have connections to the company. They’ll apply for a listing on the Canadian Stock Exchange, which is about as regulated as the pink sheets, because companies with US businesses are not accepted for trading on the major Canadian exchanges in Toronto (since their businesses are technically illegal under US law).
They are building a nice stable of big name people, I have no idea whether the actual business will be appealing (or appealingly priced), but certainly John Boehner and Bill Weld and Brian Mulroney will reap a nice windfall if the stock gets a big spike when it goes public.
Also, you might want to check with your broker to find out whether or not they can execute trades on the CSE. As far as I know, Acreage is not planning to have a coincident listing on the pick sheets in the U.S. with a five-letter symbol ending with F (for foreign) — I hope they change their minds. Acreage looks interesting, though.
Travis do you have any clarification on what iipr-a is I haven’t had any luck getting the same answer twice yet. Have held and plan to continue to hold iipr unless they change there business practices I know you have held iipr for awhile hoping you had a better explanation of iipr-a
Thanks
Rob h
That sounds like a ticker variation for the preferred shares, which my broker represents as IIPR/PA. Those are the top of the capital structure (since IIPR has no debt), and pay a higher yield, but the coupon payment will never grow and they are only a yield investment — there’s essentially no chance for capital gains, and in fact there will likely be capital losses from the current price since they can buy back (or “call”) the preferreds in October of 2022 at $25/share — that’s still a positive yield if you hold through the call date, since the coupon payments are high, but you effectively agree to sell back the preferreds at $25 and you paid $27 for them if you bought today… so the effective yield is lower than the yield you’ll see quoted. I went into some detail on this in a July Friday File when I sold my preferreds at around ~$29 for just that reason and rolled that investment back into the common stock. I’d happily buy the Preferreds at close to par, just because the lack of debt makes them essentially as guaranteed as a bond and the yield is high and should be safe… but I wouldn’t pay a large premium because of that $25 call feature.
As always thanks for the clarification that makes a lot more sence that what there contact info gave me. I bought into iipr if I am remembering your portfolio the prior month and intend to ride it out until a larger funded company steps in . They really did well and a great safe haven being out of sight out of mind until the Canadian early licenses get green light Ed to invest in the USA market .
Thanks
Heard rumour the Big P is also involved in InMed, IMLFF. Let us know if you find anything…
I too am awaiting Acreage Holdings going public. @ Steven Raimondi, thanks for update date……..interesting date 11-11, Singles Day in China, bigger retail $$ in China than Christmas in U.S. Consider going to Acreage Holdings website and sign up for their email updates. Since April I have invested in 17 Cannabis/Marijuana companies, sold 4, 13 remaining, with mostly small $2k speculative in most, a bit more in others. With last months ups and downs, I am now even.
Anyone else think there’s something a little distasteful about Boehner shilling like this? I have been in and out of CGC, HYYDF, and CRON, but the volatility is crazy. On a positive note, prices are currently crashing, so there should be good entry points coming along soon. The above are the three I’ll probably buy again.
Agree with you, Dave. Also, please see my reply below to Paula.
of course it’s distasteful. How do you think they build their bankrolls?
A year ago it was all about crypto, and now its all about marijuana. These teasers are cheaper by the dozen! But Travis is always there for us!
I think people understand the potential of MJ vs crypto…..MJ has a long way to go in the medical community and are sick and tired of always taking addictive drugs….which a lot of them are…for pain etc.
@travis
Any thoughts on CV Science, CVSI? They are also heavily focused on CBD products (oil, balms, gummies, drops, etc).
Charlottes Web: last quarter revenue $17.2m yoy growth 90%
CV Science: last quarter revenue $12.3m yoy growth 203%
CVSI didn’t run up with the rest (cannabis stocks) over the last 3 months due to an article out by Citron.
Good morning! I got into CVSI at .55 a share and kept on loading up to $4.66. Their earnings are coming out after the bell next Wed. Nov. 7. It’s not too late to take a position but of course do your homework! The earnings are expected to moved this stock into double digit not to mention that CV Science has applied for Nasdaq uplisting which will most likely happen when the Farm bill passes. They are also the first Company to be Gras Certified, they have NO debt! If your serious, educate yourself by going to their website pluscbdoil.com, seeking alpha/news, and investorshub.com where you can find useful info to help your decision! Good luck~
Folks be careful out there. It’s not so much about the company as it is about when you get in and out. Because I didn’t time things right I’ve lost money on ACBFF, TILRAY, and CANOPY. I will buy them again as they are all big MJ producers but timing is everything. John Boenher and MMPress didn’t tell me anything I didn’t already know. And they are just tons of people selling info that is out there in a lot of free publications. So don’t waste your money. Boehner is just a name to sucker people into buying info. All the companies they teased are down and doing nothing.
Paula, you’re “spot on” — all three guys in that presentation offered nothing and could barely read the teleprompters in anything remotely close to a convincing manner. For 39 bucks and a refund guarantee, it might be worthwhile to see what they produce and, then, get your money back (maybe!).
Any views out there on HEMP? (I own a small amount, FYI). At under 3 cents a share, it kinda seems like it’s on nobody’s radar, & the price is certainly a red flag, but everything I do find on them seems surprisingly positive. What am I missing?
It’s worth some risk…a slow burner….need to make and sell CBD type products I think is the best best…or put into drinks…..or sell to other MJ companies who are well known! I don’t know much about this company….don’t own it either….
on HEMP, I think they have 1-2B shareholders. You are right they do have an interesting strategy. The number of sharholders kind of holds them back. They might consider a buy back in the future if they start generating cash flow.
At 2.46 Cent I got 5000. If it goes it goes. If not O well. Good luck
What would all of you say would be the best cannabis stocks to buy right now? I am interested in companies that are the most grounded and would be good buys for a term of one year or more. I would rather have a good company that knows what it’s doing than a short-term, more risky play. Thank you!
The only honest answer I can give is Innovative Industrial Properties (IIPR), because it’s the only “cannabis stock” I own or would buy at current prices (my max “buy up to” price for IIPR is $45). I expect there to be much better buying opportunities for the “real” cannabis stocks (the big Canadian players, particularly) in the future than today, but that conservative bent has meant I’ve missed most of the surging pot stocks in the past.
My 2 cents has risen to 20 cents since late July
of 2018. Valuations however have expanded also. This Marijuana trip is New to me; however, I do believe that opportunity is frequently within reach! But Never jump into
the Pool until You know how Deep the water
is! This could be similar to the 1999-2000 Tech Wreck at a future date.
Full Disclosure:
I own many Shares of the following.
(CRON) Cronos Group
(EMHTF) Emerald Health
(MRMD) Marimed, Inc.
(HYYDF) Hexo Corp
Hope that this Helps You and Many Others!
HYYWF .otc HEXO , $ 2.20
HEXO . ARCA $5.64
HEXO..tsx $7.52
I have been an Irregular for year and half. Reading one of Travis’ articles, in April 2018 IIPR was/is my first venture into Cannabis sector. For your investigating, research, due diligence, I suggest 3 weekly (free) enewsletters.
1. Let’s Toke Business Newsletter by Ted Ohashi. Send an email to Ted tedohashi@gmail.com and ask to be added to his newsletter and what country you are from.
2. http://www.newcannabisventures.com by Alan Brochstein
3. http://www.greenmarketreport.com
Since April, I have purchased 17 Cannabis related stocks, sold 4, and 13 remaining
CGC Canopy Growth
CRON Cronos Group
GTBIF Green Thumb Industries
GWPH GW Pharmaceuticals
HYDDF HEXO Corp (formerly Hydropothecary)
IIPR Innovative Industrial Properties
KHRNF Kihron Life Sciences
LXRP Lexaria
MMNFF Medmen Enterprises
OGRMF Organigram
PLNHF Planet 13 Holdings
SNNVF Sunniva
TGODF The Green Organic Dutchman
TLRY Tilray
I am awaiting Acreage Holdings to go public in November.
Happy Investing!!
did u get GTBIF green thumb before may < u lucky dog
nope, bought GTBIF June 19, so gain 36.1%
Thank you for the great replies! Much appreciated.
Travis ,isn’t it amazing how people get away with “stealing” other peoples’ researched ideas and passing it off as their own “Original” ideas …making a lot of money as a result…..Is it Legal ?
Also ,why would Patients want to buy CBD Oils/Medicine from Charlotte’s Web for the treatment of Dravets Syndrome and Epilepsy, when the “Safer”, Medically Tested, with Patients, to FDA’s Phase III requirement and beyond ; FDA approved …The First Cannabis Medicine to get this International Status..is now available and also now in Production for a Global Launch…Heck, even the British Government have changed their mind on Cannabis Medicine purely on the basis of that G.W Pharmaceutical (GWPH) Epilepsy Breakthrough.
Is it because this British Company has not ‘ Bragged’ enough about it’s success ?
Let’s hear it for these Guys “CONGRATULATIONS GWPH !”
Not really, I expect, it’s mostly because GW Pharma’s drug will cost thousands of dollars a year and the CBD folks can slip regulatory oversight and get away with hinting at the health impacts of various Cannabidiol strains without actually proving them, which saves a lot of money and makes mass-marketed brands effective in nutritional supplements even if, of course, they are not nearly as controlled or monitored (or tested for efficacy) as actual drugs.
Pity but you’re right ! Pity also the Kids with 100 Epileptic Fits/day…it would be like giving them a ‘Dirty Street bought’ joint each day to cure their Ailments…Pity the Parents !!!
Hi Travis! have no idea where to go to post a ? to yours…
Could you enlight us about Tim Sykes strategy? What is it his weekend traiding subscription for a few thousand?
Irene A
You can always email us (ILoveStockSpam@gmail.com) or submit a question on our contact page (linked at the bottom of every page)… or comments are fine as well.
Tim Sykes has long been a guy who day-trades penny stocks, often shorting pump and dump stocks, and offers up trading classes for folks who want to do similar. People tend to either love him or hate him, but I’ve never written about him in any detail.
I am a Sykes student (3 months now), and very much into his services… He has many levels of programs (I am in the “Millionaire Masters Program”, which is a mid level deal), and am learning a LOT! IF you are mostly interested in day trading, and mostly “penny stocks”, then there are a few great resources… including Sykes’ programs… He has many detractors, but I can tell you – IF IF IF you are ready to study your ass off, and get 100% serious and totally immersed into this market, then this is a great service to get all the info you will ever need, plus ongoing support and motivation) … I will encourage you to check out his free “7 part trader checklist”… absolutely free to view on You tube or his website… and that will give you a lot of insight (about 15 hours worth) into his mindset, attitude and experience – along with many other “Guru’s” who are also involved … I can tell you he is extremely passionate and dedicated to his students and this way of life… I would also recommend “Investors Underground” as another and similar service — IF you are serious and dedicated, these 2 will take you a long way… (I am only a student, and also passionate and dedicated to make this way of life my retirement, so I am not promoting these for any other reason than I use them both)… I hope that helps – Thank you…
Thank you Travis — very much appreciated… I was assuming this was a marketing hype situation for their most expensive subscriptions… I joined MMP for $39 a while ago, and mostly just get offers to “upgrade”… so again – Thank You!!
I bought Emerald Health…and ACB….as I think CBD oil, tintures and health drinks will be ‘really big’ for health purposes. Prices are quite low now…and I see long term gains for those not in a hurry….! More studies are being done on the non-THC component of MJ. It’s just started in my opinion.
I bought CVSI (a year ago and sold later at a nice price profit)) because my wife bought some of their CBD oils and was impressed with her results. Recently she purchased some more of their products and they were on back order for delivery. I bought some more CVSI as a result. You do me a great service Travis!! Gerald
Cvsi maybe getting sued in a class action not disclosing patent disapprovals, check it out!
Don’t buy into that crap! That all came about from Citron (Andrew Left) when they were posting fake tweets that Ameritrade decided to pick up and repost which spooked the long’s. That company is known to short stocks while instilling fear so that the investors will panic sell which worked! All the ambulance chasers were out looking for investors that took a loss and guess what?….nothing will come of it except it slowed the stock from excelling! As you will know that Citron did it to TLRY also after their huge run up!
Not getting sued for disliked products the lawyers jumped in as always when they in error made a quote worded misleading dead in the water month ago for what its worth
I’m a shareholder in Charlotte’s Web, easy to see that it is the #1 CBD company in the US.
They have the most market share and the branding.
Second highest revenue in the entire MMJ/CBD combined space, and profitable for over the past year. Growing quickly and will eventually be a household name. Farm Bill passage will unlock the true potential of the company, but isn’t required for this company to continue to succeed.
I did too, so far small loss just like nearly every other stock out there. Good luck to us all.
I have personally tried 2 different HEMP oils Natures Beneficials Hemp Oil and Daily Hemp Super Hemp 500 …………Both proved “Worthless” had better results for some minor knee pain with 650 mg of aspirin, for a lot less money! I fell that most people simply imagine it to work …….and it does!
Hemp ‘seed’ oil is basically to get your Omega fatty acids which might help with some inflammatory conditions. For some people it works. I haven’t tried it…but might sometime. My wife takes Omega fatty acids 3-6-9 for that. Hayloronic (sp) misspelled acid might work for that….my wife takes it daily…it’s kind of expensive though. The Vitamin Shoppe sells it….and some others….try it. I have been looking for the ‘fountain of youth’ type supplement for years to no avail. Am familiar with herbs quite a bit….researching etc as a hobby while looking for the non drug pain reliever. I’d try a low THC maybe 1-3 % within CBD…..not .001…if the THC is too low it may not help for pain….inflammation yes; but not pain. My thoughts!
The intent of oils are to use them all the time. Not as needed. Make taking CBD oil part of your daily routine. Adjusting the frequency and dosage as needed. It will take a lot of trial and error. But, if you stick with it and figure out what works best for you. You will be forever thanking yourself for doing. Trying one dose, one time and expecting a miracle just isn’t going to happen.
I’ve tried lots of different CBD oil. Like with everything else, there’s a lot of bogus stuff out there. However, I hit on 2 that actually work for chronic pain as well as depression/anxiety. They are Endoca and Highland Pharms. I believe they’re both privately held. I own IIPR, MRMD, ACB and MJNA
$$CBD
Here’s a little checklist when buying CBD, 1) Where was the raw product sourced? Organically grown in the US or Europe? 2) How and where was it extracted? In the US? CO2 extraction is cleanest and safest 3) Is it full spectrum or “whole plant” 4) does the company provide a Certificate of Analysis from a 3rd party lab test with a batch number etc. ? If they don’t, move on. 5) read the label: really should not contain more than 3 ingredients (watch out for fillers) 5) Hemp seed oil does not contain CBD but is commonly used as a carrier oil.
Endoca is a Dutch brand and an excellent source. Been around a long time. No opinion about Highland Farms.
I work in the industry and can attest that CBD is very effective for many health concerns, sometimes with miraculous results, but it is not a “one drop fits all” supplement and for some ineffective. I personally suffer from Lupus and Fibromyalgia and medical cannabis (not just CBD alone) has allowed me to get off a load of pharmaceuticals and given me my life back.
Good for you, Simon!
And thanks to all of you. I am just getting my feet wet as an investor. I’ve not yet made a move but taking this all in and certainly appreciate all of your comments. I tripped into this blog by accident, as I was attempting to, not walk but, run from the invitation to join the NICI. What a joke. Lol! I am so glad I found you. Thank you especially Travis.
There are many different companies selling CBD oil. For pain I’d say about 3% THC within the tincture should help….! If the THC is too low….it won’t work.
KSHB, CWBHF, EMHTF, ORHOF…. got them All except CWEB !!!
Cwbhf is cweb / Charlottes web hopefully you have owned cannaroyality before 3.50 takes a long time for totality based companies in the USA to make real money being all states at least medically legal otherwise you will be hanging in the red for awaits the next jump will be threw the farm bill proceeds and cbd market starting with this weeks conferance. Good luck
CV IS pot stock Prnny..Fidelity wont let you buy anymore..also Harry Deny economist has been threatening Dow 8000 for 2 years…extreme negativity…Weiss had an economist Larry Edelson passed aeay..he warned the trouble would start in Europe and not so extreme ……now a supposed melt up on the way…during the lady few weeks of extreme sell off bitcoin and blockchain habe been fine..no extremes
Did you read in the WSJ where the Fed has said banks can pretty do whatever they want? We are on the brink of disaster.